MedTrace Logo

A Non-interventional Multi-country Cohort Study to Assess the Safety of EVUSHELD™ During Pregnancy

NCT05847140 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-12-22

No results posted yet for this study

Summary

Multi-country, non-interventional cohort study.The objective of the study is to characterise the risk of pregnancy and offspring (neonatal and infant) outcomes in pregnancies with and without exposure to EVUSHELD (used as a treatment or prophylaxis) among women of child-bearing indicated for such treatment in the real-world setting, using secondary data from US, France and Canada.

Conditions

  • Pregnancy
  • Pregnant Women
  • Pregnancy Outcome

Sponsors & Collaborators

  • Aetion, Inc.

    collaborator OTHER

  • AstraZeneca

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-27
Primary Completion
2024-01-31
Completion
2024-01-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05847140 on ClinicalTrials.gov